Pharma committee to be constituted by the centre
Advertisement
An inter ministerial coordination committee under the supervision of the central govt will soon be formed to closely monitor the growth of the 2 Lakh crore Indian pharma sector.
Department of Pharmaceuticals Secretary V K Subburaj, will supervise the committee while representatives from 10 different department or bodies will form the core member team .
So, now the pharmaceutical companies will have access to one central body to listen to their concerning issues, and getting them resolved through a common channel of communication.
"It has been decided to constitute an Inter-Ministerial Coordination Committee as recommended by the 'Task Force on Enabling Private Sector to lead the Growth of Pharmaceutical Industry'," Department of Pharmaceuticals said in a note.
The committee may also invite other government agencies/officials or representatives of industry and their associations to the meeting for more effective resolution of the pending issues.
Other members of the committee include representatives from various departments like department of industrial policy and promotion, commerce, science and technology, bio-technology, environment, health and family welfare and revenue.
Besides these, the committee will also have representatives from drug price regulator NPPA (National Pharmaceutical Pricing Authority) and Central Pollution Control Board.
The Drug Controller General of India will also be a member of the committee.
Earlier, the task force in its report had suggested that the Department of Pharmaceuticals may come up with seed capital and facilitate funding with other financial institutions for the medium and small scale players in the pharmaceuticals industry.
Department of Pharmaceuticals Secretary V K Subburaj, will supervise the committee while representatives from 10 different department or bodies will form the core member team .
So, now the pharmaceutical companies will have access to one central body to listen to their concerning issues, and getting them resolved through a common channel of communication.
"It has been decided to constitute an Inter-Ministerial Coordination Committee as recommended by the 'Task Force on Enabling Private Sector to lead the Growth of Pharmaceutical Industry'," Department of Pharmaceuticals said in a note.
The committee may also invite other government agencies/officials or representatives of industry and their associations to the meeting for more effective resolution of the pending issues.
Other members of the committee include representatives from various departments like department of industrial policy and promotion, commerce, science and technology, bio-technology, environment, health and family welfare and revenue.
Besides these, the committee will also have representatives from drug price regulator NPPA (National Pharmaceutical Pricing Authority) and Central Pollution Control Board.
The Drug Controller General of India will also be a member of the committee.
Earlier, the task force in its report had suggested that the Department of Pharmaceuticals may come up with seed capital and facilitate funding with other financial institutions for the medium and small scale players in the pharmaceuticals industry.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.